Company
Headquarters: Taipei, Taiwan
TW$7.24 Billion
TWD as of Jan. 1, 2025
US$220.6 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $75.80 B |
| Cencora, Inc. | $47.92 B |
| Cardinal Health, Inc. | $31.29 B |
| Henry Schein, Inc. | $9.32 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $9.01 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
CHC Healthcare Group, together with its subsidiaries, provides a range of healthcare management services in Taiwan and internationally. The company sells, installs, maintains, and rents medical equipment; sells pharmaceuticals; and is involved in the provision of management consultation, and hospital operation and management activities. It also offers a range of equipment in the areas of radiation oncology, neurology, medical imaging, ophthalmology, surgery, and integrated development for hospital researches. The company was founded in 1977 and is headquartered in Taipei, Taiwan.
CHC Healthcare Group has the following listings and related stock indices.
Stock: TWSE: 4164 wb_incandescent